Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs

被引:37
作者
Pericas, Juan M. [1 ]
Llopis, Jaume [1 ,2 ]
Athan, Eugene [3 ,4 ]
Hernandez-Meneses, Marta [1 ]
Hannan, Margaret M. [5 ]
Murdoch, David R. [6 ]
Kanafani, Zeina [7 ]
Freiberger, Tomas [8 ,9 ]
Strahilevitz, Jacob [10 ]
Fernandez-Hidalgo, Nuria [11 ]
Lamas, Cristiane [12 ]
Durante-Mangoni, Emanuele [13 ]
Tattevin, Pierre [14 ]
Nacinovich, Francisco [15 ]
Chu, Vivian H. [16 ]
Miro, Jose M. [1 ]
机构
[1] Univ Barcelona, Hosp Clin IDIBAPS, Infect Dis Dept, Barcelona, Spain
[2] Univ Barcelona, Dept Genet Microbiol & Stat, Barcelona, Spain
[3] Barwon Health, Dept Infect Dis, Geelong, Vic, Australia
[4] Deakin Univ, Geelong, Vic, Australia
[5] Mater Misericordiae Univ Hosp, Dept Microbiol, Dublin, Ireland
[6] Univ Otago, Dept Pathol & Biomed Sci, Christchurch, New Zealand
[7] Amer Univ Beirut, Div Infect Dis, Beirut, Lebanon
[8] Ctr Cardiovasc Surg & Transplantat, Brno, Czech Republic
[9] Masaryk Univ, Fac Med, Brno, Czech Republic
[10] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel
[11] Univ Autonoma Barcelona, Serv Malalties Infeccioses, Hosp Univ Vall dHebron, Barcelona, Spain
[12] Inst Nacl Cardiol & Unigranrio, Rio De Janeiro, Brazil
[13] Univ Campania, Monaldi Hosp, Internal Med, Naples, Italy
[14] Pontchaillou Univ Hosp, Infect Dis & Intens Care Unit, Rennes, France
[15] Inst Cardiovasc Buenos Aires, Buenos Aires, DF, Argentina
[16] Duke Univ, Sch Med, Durham, NC USA
关键词
cardiac surgery; HIV; infective endocarditis; opioid crisis; people who inject drugs; Staphylococcus aureus; INTERNATIONAL COLLABORATION; CLINICAL PRESENTATION; EPIDEMIOLOGY; ETIOLOGY;
D O I
10.1016/j.jacc.2020.11.062
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Infective endocarditis (IE) in people who inject drugs (PWID) is an emergent public health problem. OBJECTIVES The purpose of this study was to investigate IE in PWID and compare it with IE in non-PWID patients. METHODS Two prospective cohort studies (ICE-PCS and ICE-Plus databases, encompassing 8,112 IE episodes from 2000 to 2006 and 2008 to 2012, with 64 and 34 sites and 28 and 18 countries, respectively). Outcomes were compared between PWID and non-PWID patients with IE. Logistic regression analyses were performed to investigate risk factors for 6-month mortality and relapses amongst PWID. RESULTS A total of 7,616 patients (591 PWID and 7,025 non-PWID) were included. PWID patients were significantly younger (median 37.0 years [interquartile range: 29.5 to 44.2 years] vs. 63.3 years [interquartile range: 49.3 to 74.0 years]; p < 0.001), male (72.5% vs. 67.4%; p = 0.007), and presented lower rates of comorbidities except for human immunodeficiency virus, liver disease, and higher rates of prior IE. Amongst IE cases in PWID, 313 (53%) episodes involved left-side valves and 204 (34.5%) were purely left-sided IE. PWID presented a larger proportion of native IE (90.2% vs. 64.4%; p < 0.001), whereas prosthetic-IE and cardiovascular implantable electronic device-IE were more frequent in non-PWID (9.3% vs. 27.0% and 0.5% vs. 8.6%; both p < 0.001). Staphylococcus aureus caused 65.9% and 26.8% of cases in PWID and non-PWID, respectively (p < 0.001). PWID presented higher rates of systemic emboli (51.1% vs. 22.5%; p < 0.001) and persistent bacteremia (14.7% vs. 9.3%; p < 0.001). Cardiac surgery was less frequently performed (39.5% vs. 47.8%; p < 0.001), and in-hospital and 6-month mortality were lower in PWID (10.8% vs. 18.2% and 14.4% vs. 22.2%; both p < 0.001), whereas relapses were more frequent in PWID (9.5% vs. 2.8%; p < 0.001). Prior IE, left-sided IE, polymicrobial etiology, intracardiac complications, and stroke were risk factors for 6-month mortality, whereas cardiac surgery was associated with lower mortality in the PWID population. CONCLUSIONS A notable proportion of cases in PWID involve left-sided valves, prosthetic valves, or are caused by microorganisms other than S. aureus. (C) 2021 by the American College of Cardiology Foundation.
引用
收藏
页码:544 / 555
页数:12
相关论文
共 34 条
[1]   Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States [J].
Alkhouli, Mohamad ;
Alqahtani, Fahad ;
Alhajji, Muhammed ;
Berzingi, Chalak O. ;
Sohail, M. Rizwan .
MAYO CLINIC PROCEEDINGS, 2020, 95 (05) :858-866
[2]   Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs Experience from a Swedish referral hospital [J].
Asgeirsson, Hilmir ;
Thalme, Anders ;
Weiland, Ola .
MEDICINE, 2016, 95 (49) :e5617
[3]   Outcomes Associated With Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis [J].
Barocas, Joshua A. ;
Morgan, Jake R. ;
Wang, Jianing ;
McLoone, Dylan ;
Wurcel, Alysse ;
Stein, Michael D. .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (03) :472-478
[4]   Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition [J].
Benito, Natividad ;
Miro, Jose M. ;
de Lazzari, Elisa ;
Cabell, Christopher H. ;
del Rio, Ana ;
Altclas, Javier ;
Commerford, Patrick ;
Delahaye, Francois ;
Dragulescu, Stefan ;
Giamarellou, Helen ;
Habib, Gilbert ;
Kamarulzaman, Adeeba ;
Kumar, A. Sampath ;
Nacinovich, Francisco M. ;
Suter, Fredy ;
Tribouilloy, Christophe ;
Venugopal, Krishnan ;
Moreno, Asuncion ;
Fowler, Vance G., Jr. .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) :586-U5
[5]   Progress toward a global understanding of infective endocarditis - Early lessons from the International Collaboration on Endocarditis investigation [J].
Cabell, CH ;
Abrutyn, E .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (02) :255-+
[6]   Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis [J].
Carugati, M. ;
Petti, C. A. ;
Arnold, C. ;
Miro, M. ;
Pericas, J. M. ;
Garcia de la Maria, C. ;
Kanafani, Z. ;
Durante-Mangoni, E. ;
Baddley, J. ;
Wray, D. ;
Klein, J. L. ;
Delahaye, F. ;
Fernandez-Hidalgo, N. ;
Hannan, M. M. ;
Murdoch, D. ;
Bayer, A. ;
Chu, V. H. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) :6341-6349
[7]   Infective endocarditis in intravenous drug users from Italy: The increasing importance in HIV-infected patients [J].
De Rosa, F. G. ;
Cicalini, S. ;
Canta, F. ;
Audagnotto, S. ;
Cecchi, E. ;
Di Perri, G. .
INFECTION, 2007, 35 (03) :154-160
[8]   Admissions for Infective Endocarditis in Intravenous Drug Users [J].
Deo, Salil V. ;
Raza, Sajjad ;
Kalra, Ankur ;
Deo, Vaishali S. ;
Altarabsheh, Salah E. ;
Zia, Aisha ;
Khan, Muhammad Shahzeb ;
Markowitz, Alan H. ;
Sabik, Joseph F., III ;
Park, Soon J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (14) :1596-1597
[9]   Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis [J].
Goodman-Meza, David ;
Weiss, Robert E. ;
Gamboa, Sebastian ;
Gallegos, Abel ;
Bui, Alex A. T. ;
Goetz, Matthew B. ;
Shoptaw, Steven ;
Landovitz, Raphael J. .
BMC INFECTIOUS DISEASES, 2019, 19 (01)
[10]   Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study [J].
Habib, Gilbert ;
Erba, Paola Anna ;
Iung, Bernard ;
Donal, Erwan ;
Cosyns, Bernard ;
Laroche, Cecile ;
Popescu, Bogdan A. ;
Prendergast, Bernard ;
Tornos, Pilar ;
Sadeghpour, Anita ;
Oliver, Leopold ;
Vaskelyte, Jolanta-Justina ;
Sow, Rouguiatou ;
Axler, Olivier ;
Maggioni, Aldo P. ;
Lancellotti, Patrizio ;
Granada, I ;
Mahia, M. ;
Ressi, S. ;
Nacinovich, F. ;
Iribarren, A. ;
Fernandez Oses, P. ;
Avegliano, G. ;
Filipini, E. ;
Obregon, R. ;
Bangher, M. ;
Dho, J. ;
Cartasegna, L. ;
Plastino, M. L. ;
Novas, V ;
Shigel, C. ;
Reyes, G. ;
De Santos, M. ;
Gastaldello, N. ;
Granillo Fernandez, M. ;
Potito, M. ;
Streitenberger, G. ;
Velazco, P. ;
Casabe, J. H. ;
Cortes, C. ;
Guevara, E. ;
Salmo, F. ;
Seijo, M. ;
Weidinger, F. ;
Heger, M. ;
Brooks, R. ;
Stollberger, C. ;
Ho, C-Y ;
Perschy, L. ;
Puskas, L. .
EUROPEAN HEART JOURNAL, 2019, 40 (39) :3222-+